Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma
NCT01650090Phase 2Completed
- Sponsor
- Eleison Pharmaceuticals
- Start
- Aug 2012
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Inhaled Lipid Cisplatin in osteosarcoma (OS), sponsored by Eleison Pharmaceuticals. Started Aug 2012; status: completed.
02
Drugs
Inhaled Lipid Cisplatin
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on NCT01650090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01650090.